NTLA vs QDEL
Intellia Therapeutics, Inc. and QuidelOrtho Corp., side by side — 6 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | NTLA | QDEL |
|---|---|---|
| Revenue | $67.7M | $2.7B |
| Net income | $-412.7M | $-1.1B |
| Gross margin | · | 46.7% |
| Net margin | −609.9% | −41.5% |
| Return on equity | −53.5% | −46.1% |
| Diluted EPS | −$3.81 | −$16.69 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | $-395.9M | $-83.0M |
| Equity | $671.4M | $1.9B |
| Net debt / equity | · | 1.41× |
| Current ratio | 5.08× | 1.50× |
| Revenue CAGR 5y | 3.1% | 10.4% |
| Profit CAGR 5y | · | · |
QDEL bills 40.3× the revenue of NTLA, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
6 years side by side
| Fiscal year | NTLA | QDEL |
|---|---|---|
| FY2025 | $67.7M | $2.7B |
| FY2024 | $57.9M | $2.8B |
| FY2023 | $36.3M | $3.0B |
| FY2022 | $52.1M | $3.3B |
| FY2021 | $33.1M | $1.7B |
| FY2020 | $58.0M | $1.7B |
Bottom line
| Fiscal year | NTLA | QDEL |
|---|---|---|
| FY2025 | $-412.7M | $-1.1B |
| FY2024 | $-519.0M | $-2.1B |
| FY2023 | $-481.2M | $-10.1M |
| FY2022 | $-474.2M | $548.7M |
| FY2021 | $-267.9M | $704.2M |
| FY2020 | $-134.2M | $810.3M |
6 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$2,662,529,000 | QDEL |
| FY2024 | −$2,725,023,000 | QDEL |
| FY2023 | −$2,961,525,000 | QDEL |
| FY2022 | −$3,213,879,000 | QDEL |
| FY2021 | −$1,665,547,000 | QDEL |
| FY2020 | −$1,603,706,000 | QDEL |
QDEL has reported the higher revenue in every one of these 6 fiscal years. The gap has widened since the earliest year compared.
6 of 10 comparable fiscal years — a year missing data on either side is not counted.
6 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −568.4 pp | QDEL |
| FY2024 | −823.0 pp | QDEL |
| FY2023 | −1326.2 pp | QDEL |
| FY2022 | −926.6 pp | QDEL |
| FY2021 | −851.9 pp | QDEL |
| FY2020 | −280.2 pp | QDEL |
QDEL has kept the higher net margin in every one of these 6 fiscal years.
6 of 10 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
NTLA's net margin has been more volatile than QDEL's over the 6 comparable fiscal years — 331.2 percentage points of standard deviation against 43.8.
6 of 10 comparable fiscal years — a year missing data on either side is not counted.
Year by year
QDEL led in net margin in every one of the 6 comparable fiscal years — a structural lead, not a recent swing.
6 of 10 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
QDEL's return on equity has been more volatile than NTLA's over the 6 comparable fiscal years — 41.8 percentage points of standard deviation against 8.1.
6 of 9 comparable fiscal years — a year missing data on either side is not counted.
Year by year
QDEL led in return on equity in every one of the 6 comparable fiscal years — a structural lead, not a recent swing.
6 of 9 comparable fiscal years — a year missing data on either side is not counted.